Rephonic
Artwork for BiotechTV

BiotechTV - News

BiotechTV
Orexin
FDA
Narcolepsy
Takeda
Alkermes
Biogen
Alnylam
Biotechnology
Pfizer
Cedar
Biotech Sector
Xenon
Stoke
China
Clinical Trials
RNA Interference
AI In Biotech
Duchenne Muscular Dystrophy
Axsome Therapeutics
Peanut Allergy

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

PublishesDailyEpisodes249Founded8 months ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for BiotechTV

Latest Episodes

Co-Founder & CEO Laurent Martinot discusses the raise, and the need for more accessible sleep health care. Plus, previewing a clinical trial of its device that will read out shortly.

CEO Craig Marshall describes how the company's "metra" device pumps blood through donor organs (currently livers) in order to extend the amount of time they can be transplanted safely.

CEO Ros Deegan discusses the deal and the path to getting there, and she highlights some of OMass' other programs the company is driving forward alone, including an MC2 antagonist. Plus, the company's unique expertise in the use of mass spec.

He discusses the rally biotech has had of late, and that was boosted by Pfizer's deal with the White House. Plus, how interest rates, employment, and other factors are affecting the broader economy, and might impact biotech.

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Recent Guests

Ros Deegan
Chief Executive of OMass Therapeutics
OMass Therapeutics
Episode: Oxford, UK based OMass Therapeutics, experts in the use of mass spectrometry in drug development, recently landed a $20M up front licensing deal with Roche on one of its preclinical candidates for IBF
Ben Zeskind
Co-founder and CEO of Immuneering.
Immuneering
Episode: Immuneering's CEO walks us through the company's MEK data in pancreatic cancer, and explains the science behind 'deep cyclic inhibition'
Rafiq Hasan
CEO of Complement Therapeutics, physician with experience in clinical development and pharmaceuticals.
Complement Therapeutics
Episode: Complement Therapeutics received IND clearance from U.S. FDA today to start a trial of its AAV gene therapy for geographic atrophy that delivers a truncated version of Complement Receptor 1 to the eye
Nabanita Nawar
Co-founder and CEO of HDAX Therapeutics
HDAX Therapeutics
Episode: Align Summit: Toronto based HDAX Therapeutics believes there are many indications to tackle with its dual binding approach to HDAC6
Aaron Edwards
Co-founder and CEO of KiraGen Bio
KiraGen Bio
Episode: Align Summit: Allston based KiraGen Bio is aiming to program CAR-T cells to tune out the suppressive nature of the tumor micro environment. The first program will be for GBM.
Ashoka Rejendra
Founder and CEO of Orchestra Bio
Orchestra Bio
Episode: After exiting stealth with $20 million two weeks ago, Orchestra Bio is out to help science entrepreneurs handle the dollars and cents management and long term planning that business requires
Kendalle Burlin O'Connell
CEO of MassBio, representing innovators in the biotech industry
MassBio
Episode: Biotech Direct: MassBio CEO Kendalle Burlin O'Connell and Seaport Therapeutics Founder & CEO Daphne Zohar discuss NIH funding, recent developments at FDA, and improving the public's view of science
Daphne Zohar
Founder and CEO of Seaport Therapeutics, serial entrepreneur
Seaport Therapeutics
Episode: Biotech Direct: MassBio CEO Kendalle Burlin O'Connell and Seaport Therapeutics Founder & CEO Daphne Zohar discuss NIH funding, recent developments at FDA, and improving the public's view of science
Warner Biddle
CEO of Kyverna, focused on CAR-T therapies for autoimmune conditions.
Kyverna
Episode: Checking in on the progress of CAR-T for autoimmune conditions with the CEO of Kyverna - the company's first (and first for the field) registration intended trial will read in the first half of 2026

Hosts

Ryan Flynn
Host who introduces and talks with guests about various biotech developments and industry insights.
Brad
Host who introduces and engages in discussions with guests about biotechnology news and trends.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Biotech veteran David Hung talks about the launch of IBTROZI in ROS1 positive non-small cell lung cancer, and what's next for Nuvation Bio
Q: What can you say about how the launch is going so far?
In the first seven weeks post-approval, they reported a significant number of patients on the drug, indicating a strong market entry.
Biotech veteran David Hung talks about the launch of IBTROZI in ROS1 positive non-small cell lung cancer, and what's next for Nuvation Bio
Q: What is the unmet need and how does Ibtrozi fit into the competitive picture with other market drugs?
Ibtrozi shows superior efficacy with an 89% response rate and a 4-year progression-free survival rate, compared to around 70% and 18 months for existing therapies.
Complement Therapeutics received IND clearance from U.S. FDA today to start a trial of its AAV gene therapy for geographic atrophy that delivers a truncated version of Complement Receptor 1 to the eye
Q: What are the key aspects of the iGain trial?
The iGain trial is designed to profile a large cohort of patients to understand the heterogeneity of geographic atrophy and will compare pre-treatment baseline data with post-treatment outcomes.
Complement Therapeutics received IND clearance from U.S. FDA today to start a trial of its AAV gene therapy for geographic atrophy that delivers a truncated version of Complement Receptor 1 to the eye
Q: How does your mechanism compare to existing therapies?
Rafiq explains that their approach is targeting upstream mechanisms of the complement cascade which enhances efficacy, contrasting it with existing therapies that require frequent dosing.
Complement Therapeutics received IND clearance from U.S. FDA today to start a trial of its AAV gene therapy for geographic atrophy that delivers a truncated version of Complement Receptor 1 to the eye
Q: Can you introduce yourself and Complement Therapeutics?
Rafiq Hasan introduces himself as the CEO, sharing his extensive background in the pharmaceutical industry and discussing the company's focus on developing gene therapy for geographic atrophy.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BiotechTV

What is BiotechTV about and what kind of topics does it cover?

The content primarily revolves around recent developments in the biotechnology sector, emphasizing breakthroughs in medical research, treatments, and the implications of regulatory changes. Episodes often feature in-depth discussions with industry leaders, including CEOs and innovators from biotech companies, who provide insights into emerging technologies, clinical trials, and market dynamics. The focus on integrating AI into healthcare and the exploration of novel therapeutic strategies illustrate the podcast's commitment to shedding light on critical advancements impacting public health and patient care. This highlights their role not just as an information conduit but as a platform fostering dialogue on pressing issues within the life s... more

Where can I find podcast stats for BiotechTV?

Rephonic provides a wide range of podcast stats for BiotechTV. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BiotechTV and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BiotechTV get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for BiotechTV, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BiotechTV?

Rephonic provides comprehensive predictive audience data for BiotechTV, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BiotechTV have?

To see how many followers or subscribers BiotechTV has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BiotechTV?

These podcasts share a similar audience with BiotechTV:

1. Biotech Hangout
2. BioCentury This Week
3. The Readout Loud
4. BioVenture VoiCes with Chris Garabedian
5. The Studio at Kendall Square

How many episodes of BiotechTV are there?

BiotechTV launched 8 months ago and published 249 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BiotechTV?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BiotechTV?

Rephonic pulls ratings and reviews for BiotechTV from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BiotechTV?

Rephonic provides full transcripts for episodes of BiotechTV. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BiotechTV?

Recent guests on BiotechTV include:

1. Ros Deegan
2. Ben Zeskind
3. Rafiq Hasan
4. Nabanita Nawar
5. Aaron Edwards
6. Ashoka Rejendra
7. Kendalle Burlin O'Connell
8. Daphne Zohar

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days